Background/Aims: Lemur tyrosine kinase (LMTK)-3 is a member of the receptor tyrosine kinase (RTK) family. Abnormal expression of LMTK-3 exists in various types of cancers, especially in endocrine-resistant breast cancers; however, the precise level of expression and the biological function in prostate cancer are poorly understood. Methods: In the present study, we determined the expression of LMTK-3 in prostate cancer using immunohistochemistry and Western blotting. We infected PC3 and LNCaP cells with lentivirus-LMTK-3 and observed the biologic characteristics of the PC3 and LNCaP cells in vitro with TUNEL, and migration and invasion assays, respectively. We also established a transplant tumor model of human prostate cancer with infected cells in 15 BALB/c-nu/nu nude mice. Results: LMTK-3 was expressed in prostate epithelial cells. There was a significant decline in the level of LMTK-3 expression in prostate cancers compared to normal tissues. LMTK-3 inhibited PC3 and LNCaP cell growth, migration, and invasion, and induced cell apoptosis in vitro. We also observed that LMTK-3 induced PC3 cell apoptosis in vivo. Further study showed that LMTK-3 inhibited phosphorylation of AKT and ERK, and promoted phosphorylation and activation of p38 kinase and Jun kinase (JNK). Conclusion: Recombinant lentivirus with enhanced expression of LMTK-3 inhibited prostate cancer cell growth and induced apoptosis in vitro and in vivo. AKT and MAPK signaling pathways may contribute to the process.
prognosis of cancer [4] . Androgen, and the androgen receptor (AR) play a critical role in the development and progression of PCa and are the main targets for therapy; however, almost all patients develop castration-resistant PCa after a period of treatment [5] [6] [7] . Thus, new targets and treatment strategies are needed for PCa therapy. Lemur tyrosine kinase (LMTK)-3 belongs to the serine-threonine-tyrosine kinases family. Studies have shown that abnormal expression of LMTK-3 is related to a number of malignant tumor types. LMTK-3 is significantly increased in human non-small cell lung cancer, and can be used as a biomarker to screen for primary non-small cell lung cancer and predict progression [8] . Lenz et al [9] . reported that LMTK-3 polymorphisms serve as a candidate prognostic factor for gastric cancer. Jiang et al [10] . confirmed that serum LMTK-3 is a valuable biomarker for predicting the progression and prognosis of patients with colorectal cancer. Giamas et al. showed that high LMTK-3 is associated with proliferation of breast cancer, and silencing LMTK-3 reduces tumor volume [11] . LMTK-3 also contributes to endocrine resistance through estrogen receptor (ER)-α activity [12] , however, the expression of LMTK-3 in PCa and the effect on PCa are still obscure.
In the current study we demonstrated that LMTK-3 is present in prostate epithelial cells. The expression of LMTK-3 was lower in PCa tissues compared with adjacent non-cancer tissues. We further explored the effect of LMTK-3 on PCa in vitro and in vivo, and the possible underlying mechanism.
Materials and Methods

Patients and tissue samples
Thirty-two paired PCa and adjacent normal prostate tissue samples were obtained from patients who underwent radical prostatectomies in the Department of Urology of the Fourth Affiliated Hospital of Harbin Medicine University (Harbin Heilongjiang, China). The tissues were separated and stored in liquid nitrogen until used. The 32 patients did not receive chemotherapy or radiotherapy and gave informed consent to participate in the study. Approval of the Ethics Committee of the Fourth Affiliated Hospital of Harbin Medical University was obtained. The clinicopathologic characteristics of the patients are presented in Table 1 .
Immunohistochemical staining
The tissues from 32 patients were fixed in 10% neutral formalin, then embedded in paraffin. Immunohistochemistry staining was performed on 4-µm paraffin sections. Briefly, paraffin sections were dewaxed with gradient alcohol and endogenous peroxidase was blocked for 20 min in 0.3% hydrogen peroxide in water. For pressure cooker antigen repair, the slides were treated in citrate buffer at 121°C for 5 min. After cooling to room temperature, sections were incubated with rabbit anti-LMTK-3 antibodies (1:500 dilution, NBP1-82887; Novus Biologicals, Littleton, CO, USA) at 4°C, thrice-washed with phosphate-buffered saline, then incubated with rabbit secondary antibodies for 20 min inside a humidor at room temperature. LMTK-3 expression was visualized with 3, 3-diaminobenzidine tetrahydrochloride, counterstained with Mayer's hematoxylin, dehydrated in gradient alcohol, sealed with neutral resin, and kept in the oven at 60°C for 48 h. Cell cultures PC3 and LNCaP cells were obtained from the Cell Bank of the Chinese Academy of Science (Shanghai, China) and cultured in RPMI-1640 medium supplemented with 10% heated-inactivated fetal bovine serum (FBS; Gibco, New York, NY,,USA). Incubations were carried out at 37 °C in a humidified atmosphere of 5% CO 2 . Cells in the logarithmic growth phase were used for further experiments.
Lentivirus infection and transfection of siRNA Plasmid vector pLenti6.3-LMTK3-IRES-EGFP and control recombinant lentivirus (Lv-LMTK3 and Lv were constructed by the Genechem Company (Shanghai, China). A total of 1× 10 5 cells were seeded in a 6-well cell plate and incubated for 12 h to reach 30% confluence, then infected with Lv-LMTK3 (LMTK3 overexpression group), Lv (negative control group), and no infection (non-transfected control group) at a multiplicity of infection (MOI) of 20 transducing units (TUs) per cell. After infection for 4 h, virusfree medium with 10% FBS was changed to culture the cells. Three days later, the efficiency of infection was generally determined by observing the expression of GFP density contained by lentivirus. Then, the cells were harvested for real-time quantitative polymerase chain reaction analysis. siRNA (50 nM) and its negative controls (Gene Pharma, Shanghai, China) were transfected using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in serum-free Opti-MEM (Invitrogen) according to the manufacturer's instructions. Cells were collected 48 h later. Transfection efficiency was confirmed by real-time PCR. All siRNA sequences are listed in Table 2 .
Animals and heterotopic tumor growth assay
Four-week-old male BALB/c-nu/nu mice were obtained from The Laboratory Animal Center of Shanghai. All animal procedures were approved by the Institutional Animal Care and Use Committee at the Fourth Hospital Affiliated to Harbin Medical University. The nude mice were randomly assigned into 3 groups (n=5). To establish the xenografts, 1×10 6 infected PC3 cells were injected subcutaneously in nude mice with Matrigel (BD Bioscience, San Jose, CA, USA). Animals were carefully monitored, and tumor volume was measured by caliper measurement every 2 days and calculated according to the following formula: volume=length× width 2 /2. The curve of the tumor volume was drawn. Two weeks after implantation, the mice were sacrificed and the xenografts were further analyzed through Western blot, real-time quantitative polymerase chain reaction analysis, and a TUNEL assay.
Cell viability assay The MTT assay was used to analyze the viability of PC3 and LNCaP cells after treatment with Lv-LMTK3 and siRNA. The cells were seeded separately at an equivalent density of 2x10 3 cells/well in 96-well plates and cultured at 37°C for 4 days. Then, 10 µl (5 mg/ml) of MTT (Sigma, St. Louis, MO, USA) was added to each well. After a 4-h incubation with MTT at 37 °C, the supernatant was removed and 150 μl of dimethyl sulfoxide (DMSO; Sigma) was added to each well to dissolve the crystal. Ten minutes later, the absorbance was measured at 490 nm with a microplate reader. Each assay was performed in triplicate.
Migration and invasion assays
To determine the effect of LMTK3 on cell migration, the Transwell assay was carried out. Briefly, infected and non-infected cells were suspended (1×10 5 /well) in the upper chambers (Corning, Cambridge, MA. USA) containing 200 μL of serum-free RPMI-1640 medium. Medium containing 10% FBS was then added to the lower chamber as a chemoattractant. After incubation for 24 h, the non-migrating cells on the polycarbonate membranes were wiped off using a cotton swab. Then, the polycarbonate membranes were handled with 4% paraformaldehyde for 30 min and stained with 0.2% crystal violet for 20 min. The number of cells that had crossed through the polycarbonate membranes was recorded and analyzed. Matrigel-precoated Transwell inserts (BD Bioscience, San Jose, CA, USA) were used for the cell invasion assay. The membrane at the bottom of the Transwell chamber was coated with a 1:8 Matrigel suspension, followed by a 1-h incubation at room temperature. Similarly, the lower chamber was filled with 10% FBS 
TUNEL assays
Apoptosis was evaluated using the TUNEL assay. The pre-treated PC3 and LNCaP cells (1×10 4 ) were seeded on coverslips in 6-well plates and cultured for 3 days. Then, the coverslips were fixed, permeabilized, and stained using an In Situ Cell Death Detection Kit (Roche, Mannheim, Germany) according to the manufacturer's instructions. Portions of the xenografts were fixed with 10% paraformaldehyde. Sixmicrometer thick frozen sections were also detected by staining xenografts with the In Situ Cell Death Detection Kit, according to the manufacturer's instructions. After TUNEL staining, the frozen sections were immerged into DAPI (Invitrogen) solution to stain nuclei. Fluorescence staining was viewed by a laser scanning confocal microscope (FV300; Olympus, Tokyo Japan). Each stained section was examined under a high power field (magnification, ×400).
Quantitative real-time polymerase chain reaction (qRT-PCR)
Total RNA was extracted using Trizol reagent (Invitrogen) from PCa tissues, adjacent normal prostate tissues, PC3 cells, LNCaP cells, and xenografts. For determination of LMTK3 expression, qRT-PCR was performed using SYBR Green Real-time PCR Master Mix (Takara, , Japan) according to the manufacturer's protocol. Relative expression was normalized to the expression of U6 small RNA and evaluated using SDS2.4 software (Applied Biosystems, Foster City, CA,USA) . The primers are listed in Table 2 .
Western blot
The protein samples were extracted from the paired tissue samples, two PCa cells, and the xenografts. After quantification, proteins were separated by SDS-PAGE and transferred to a nitrocellulose membrane (Bio-Rad, Hercules, CA USA). After blocking with 5% non-fat milk in Tris-buffered saline with Tween (TBST) for 2 h, the membrane was incubated with the following primary antibodies in 5% milk TBST: LMTK-3 
Statistical analysis
The data are expressed as the mean ± SEM. All analyses were performed using GraphPad Prism (version 5.0) and SPSS 14.0. Two-tailed values of P < 0.05 were considered statistically significant with Student's t-test.
Results
The localization and expression of LMTK3 protein in prostate tissues
The aberrant expression of LMTK-3 has been observed in several human malignancie s [8] [9] [10] [11] [12] ; however, the localization and level of LMTK-3 expression in prostate tissues is still unknown. In the current study, immunohistochemical staining was used to locate the LMTK-3 protein. As shown in Fig. 1, LMTK-3 Fig. 2A and 2B, the level of LMTK-3 expression was significantly lower in the tumor specimens compared with normal tissues.
Overexpression of LMTK-3 decreased the viability of PC3 and LNCaP cells in vitro
To investigate the influence of LMTK-3 on the biologic behavior of PCa cells, we infected PC3 and LNCaP cells with recombinant LV-LMTK-3 and determined cell viability. At the same time, we knocked down LMTK-3 with siRNA in the two cell lines and examined cell viability. qRT-PCR was performed to guarantee the efficiency of transfection. As shown in Fig. 3A and 3C, the expression of LMTK-3 was significantly increased when the two cell lines transfected with Lv-LMTK3 were compared with the control and Lv groups. The level of LMTK-3 expression decreased when using siRNA. The MTT assay showed that overexpression of LMTK-3 significantly decreased the viability of PC3 and LNCaP cells compared with the control and Lv groups ( Fig. 3B and 3D , p P<0.01); however, there was no obvious difference after LMTK-3 knockdown with siRNA.
LMTK-3 attenuated the migration and invasion potential of PC3 and LNCaP cells in vitro
The invasion and migration ability of tumor cells is crucial for tumor progression. To observe the effect of LMTK-3 on cell migration and invasion, the Transwell and Matrigel invasion assays were used, respectively. The migratory potential of the Lv-LMTK-3-infected PC3 and LNCaP cells was significantly reduced (Fig. 4 A and C) . Moreover, the Matrigel invasion assay showed that the invasion of PC3 and LNCaP cells was inhibited by LMTK-3 compared to the control group (Fig. 4 B and D) . 
Overexpression of LMTK-3 induced apoptosis of PC3 and LNCaP cells in vitro
To investigate whether or not LMTK-3 can induce PCa cell apoptosis, the TUNEL assay was used to examine cell apoptosis (Fig. 5A and B) . We found that apoptosis was increased in PC3 and LNCaP cells after infection with Lv-LMTK3 in vitro (Fig. 5C and D, p＜0.05) . We also examined the expression of apoptosis-related protein, including Bax, Bcl-2, and caspase-3. As expected, the expression of Bax and caspase-3 was increased in PC3 cells (Fig. 5F and G, p＜0.05) and LNCaP cells (Fig. 5I and J, p＜0.05) . By contrast, the expression of Bcl-2 was decreased in PC3 and LNCaP cells (Fig. 5E and H, p＜0.05) . Fig.  3B and D) .** represents p<0.05. 
LMTK-3 inhibited tumorigenicity of PC3 cells and induced apoptosis in vivo
We constructed the subcutaneous tumor model with infected and uninfected PC3 cells to further verify the effect of LMTK-3 on tumor growth in vivo. An equal amount of PC3 cells was injected subcutaneously in nude mice. The expression of LMTK-3 in xenografts was much higher in the Lv-LMTK3 group than the control group at the mRNA and protein levels, suggesting that we successfully overexpressed LMTK-3 in vivo (Fig. 6A and 6B, p＜0.05 ). The volume of tumors was significantly smaller in the Lv-LMTK-3 group compared with the control group (Fig. 6C and 6D, p＜0 .05). To further confirm the mechanism underlying LMTK-3-induced tumorigenicity of PC3 cells in vivo, TUNEL staining was performed. We found that LMTK-3 increased the ratio of apoptosis cells in vivo (Fig. 6E and 6F, p＜0.05) . At the same time, we sacrificed the mice and performed a proteomic analysis of tumor tissue, and found that the expression of apoptosis-related proteins changed. As shown in Fig. 6G , the expression of Bcl-2 was decreased (p＜0.05). Instead, the expression of Bax and caspase-3 was increased (Fig. 6H and I 
The PI3K/AKT and mitogen-activated protein kinase (MAPK) signaling pathways are involved in LMTK-3-induced apoptosis
To explore the possible mechanism underlying LMTK-3-induced apoptosis, we examined the expression of subfamilies of MAPKs. Western blot analysis showed that the expression of total AKT, P38, ERK, and JNK did not change; however, phosphorylated AKT and ERK1/2 were down-regulated after LMTK-3 treatment (Fig. 7A and 7C, p＜0.05) . In contrast, phosphorylated p38 and JNK were significantly increased ( Fig. 7B and 7D, p＜0.05 ). In addition, we detected the mechanism of LMTK3 induced apoptosis in vivo. Similar to the in vitro experiments, there were no significant differences in AKT, P-38, ERK, and JNK expression between the different groups of xenografts. P-AKT and P-ERK were downregulated, whereas the expression of P-P38 and P-JNK was up-regulated ( Fig. 8A -D, p<0.05) . In summary, the data demonstrated that the PI3K/AKT and MAPK signaling pathways may contribute to LMTK-3-induced apoptosis. 
Discussion
Studies showed that abnormal expression of LMTK-3 was identified in several types of cancers, including breast, non-small cell lung, colorectal, and gastric cancer, which may serve as a new reliable diagnostic and independent prognostic biomarker in these cancers [8] [9] [10] ; however, the expression of LMTK-3 in PCa and the effect of LMTK-3 on PCa are still unclear. In the current study, we showed that the expression of LMTK-3 in PCa was decreased compared with normal prostate tissues, which suggested that LMTK-3 may act as a tumor suppressor in PCa.
To observe the influence of LMTK-3 on malignant biologic behavior, the PC3 and LNCaP cell lines were cultured and infected by lentiviurs to deliver LMTK-3. We showed that LMTK-3 inhibited the viability and induced apoptosis of the two cell lines in vitro. The migration and invasion of PC3 and LNCaP cells were also inhibited. We also constructed a subcutaneous tumor model in nude mice to verify the effect of LMTK-3 on the growth of PCa cells in vivo, and found that LMTK-3 indeed inhibited tumor growth and decreased tumor volume. The apoptosis rate was also increased in vivo after infection with LMTK-3 lentivirus. We examined the expression of apoptosis-related proteins and showed that LMTK3 increased the level of Bcl-2 protein, and attenuated the expression of Bax and caspase-3 proteins in vitro and in vivo [13, 14] . Thus, we concluded that the tumor suppression effect of LMTK-3 in PCa was mediated by regulating cell apoptosis. It is well-known that the three most important subfamilies of MAPKs (extracellular signal regulated kinases 1 and 2 [ERK1/2], c-Jun NH2-terminal kinase [JNK] , and p38 mitogenactivated protein) play a key role in cell growth, differentiation, and apoptosis in response to a variety of stresses or stimuli, including cancers [15] [16] [17] . The phosphatidylinositol 3-kinase/protein kinase-B (PI3K/ AKT) cell signaling cascade is another important intracellular pathway, is frequently activated in diverse cancers, and regulates cell proliferation, cell differentiation, cellular apoptosis, and cancer cell survival [18, 19] . Studies have shown that AKT activation is also involved in migration of PCa cells [20] . We examined activation of the AKT, p38MAPK, JNK, and ERK signaling pathways in PC3 cells and xenografts to explore the possible mechanism underlying the LMTK-3 effect. We found that LMTK-3 increased phosphorylated p38 and JNK, but decreased phosphorylated ERK1/2 and AKT. These data indicate that the change in these signaling pathways after overexpression of LMTKs may contribute to biologic behavior changes of PCa, especially cell apoptosis.
Conclusion
In summary, we found that the expression of LMTK-3 was lower in PCa tissues than normal tissues. LMTK-3 induced PCa apoptosis in vitro and in vivo; the AKT and MAPK signaling pathways may contribute to the process. LMTK-3 may be a promising intervention target in the management of PCas.
